Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Company research

YD Biopharma Ltd

CIK 2048877Updated Sep 26, 2026

No exchange listing on record for this SEC filer. Coverage is drawn from its filings.

Filing activity

SEC EDGAR
Latest filing

15-15D · Sep 8, 2025

19 filings on record · 15-15D, EFFECT, 424B3, F-4/A, CORRESP.

Recent filings

  1. 15-15D filing

    15-15D · 2025-09-08 · 0001213900-25-085390

  2. EFFECT filing

    EFFECT · 2025-07-18 · 9999999995-25-002276

  3. 424B3 filing

    424B3 · 2025-07-18 · 0001213900-25-065769

  4. F-4/A filing

    F-4/A · 2025-07-16 · 0001213900-25-064405

  5. CORRESP filing

    CORRESP · 2025-07-10 · 0001213900-25-062759

Show 5 more recent filings

  1. F-4/A filing

    F-4/A · 2025-07-10 · 0001213900-25-062745

  2. CORRESP filing

    CORRESP · 2025-07-07 · 0001213900-25-061831

  3. F-4/A filing

    F-4/A · 2025-07-07 · 0001213900-25-061830

  4. CORRESP filing

    CORRESP · 2025-06-30 · 0001213900-25-059322

  5. F-4/A filing

    F-4/A · 2025-06-30 · 0001213900-25-059319

Offerings

Registration 333-283428

F-4/A · 2025-07-16 · 0001213900-25-064405

Terms from the governing filing for this registration; not a claim that the offering is open today.

Registration 333-283428-01

F-4/A · 2025-07-16 · 0001213900-25-064405

Terms from the governing filing for this registration; not a claim that the offering is open today.